Author:
Barros Scott A.,Martin Rory B.
Reference22 articles.
1. Kola, I. and Landis, J. (2004) Can the pharmaceutical industryreduce attrition rates? Nat. Rev. Drug Discov. 3,711–715.
2. DiMasi, J., Hansen, R., and Grabowski, H. (2003) The price ofinnovation: new estimates of drug development costs. J. HealthEcon. 22, 151–185.
3. Dambach, D.M., Andrews, B.A., and Moulin, F. (2005) New technologiesand screening strategies for hepatotoxicity: use of in vitromodels. Toxicol. Pathol. 33, 17–26.
4. Kaplowitz, N. (2005) Idiosyncratic drug hepatotoxicity. Nat.Rev. Drug Discov. 4, 489–499.
5. Raghavan, N., Amaratunga, D., Nie, A., and McMillian, M. (2004) Class prediction in toxicogenomics. J. Biopharm. Stat. 15, 327–341.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献